🇺🇸 FDA
Patent

US 7098345

Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-YL)methyl]-4H-carbazol-4-one

granted A61PA61P1/08

Quick answer

US patent 7098345 (Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-YL)methyl]-4H-carbazol-4-one) held by TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság
Grant date
Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P1/08